Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to $3.8 million.

  • Ptc Therapeutics' Treasury Shares rose 535.2% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 535.2%. This contributed to the annual value of $3.5 million for FY2024, which is 2307.2% up from last year.
  • As of Q3 2025, Ptc Therapeutics' Treasury Shares stood at $3.8 million, which was up 535.2% from $3.8 million recorded in Q2 2025.
  • Ptc Therapeutics' Treasury Shares' 5-year high stood at $3.9 million during Q1 2025, with a 5-year trough of $1.5 million in Q1 2021.
  • Its 5-year average for Treasury Shares is $2.9 million, with a median of $3.4 million in 2023.
  • Its Treasury Shares has fluctuated over the past 5 years, first soared by 6826.69% in 2022, then crashed by 38.97% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Treasury Shares (Quarter) stood at $1.5 million in 2021, then surged by 65.57% to $2.5 million in 2022, then rose by 13.91% to $2.9 million in 2023, then increased by 23.07% to $3.5 million in 2024, then grew by 7.41% to $3.8 million in 2025.
  • Its Treasury Shares was $3.8 million in Q3 2025, compared to $3.8 million in Q2 2025 and $3.9 million in Q1 2025.